Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Oxi-4503 Dipotassium
2. Q9f7qeh36f
3. Combretastatin A-1 Bis(phosphate) Dipotassium Salt
4. 1,2-benzenediol, 3-methoxy-6-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, 1,2-bis(dihydrogen Phosphate), Potassium Salt (1:2)
5. 1014615-46-3
6. Unii-q9f7qeh36f
7. Q27287150
| Molecular Weight | 568.5 g/mol |
|---|---|
| Molecular Formula | C18H20K2O12P2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 10 |
| Exact Mass | 567.9704130 g/mol |
| Monoisotopic Mass | 567.9704130 g/mol |
| Topological Polar Surface Area | 176 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 688 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A Combretastatin A1 Diphosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Combretastatin A1 Diphosphate, including repackagers and relabelers. The FDA regulates Combretastatin A1 Diphosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Combretastatin A1 Diphosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Combretastatin A1 Diphosphate supplier is an individual or a company that provides Combretastatin A1 Diphosphate active pharmaceutical ingredient (API) or Combretastatin A1 Diphosphate finished formulations upon request. The Combretastatin A1 Diphosphate suppliers may include Combretastatin A1 Diphosphate API manufacturers, exporters, distributors and traders.
Combretastatin A1 Diphosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Combretastatin A1 Diphosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Combretastatin A1 Diphosphate GMP manufacturer or Combretastatin A1 Diphosphate GMP API supplier for your needs.
A Combretastatin A1 Diphosphate CoA (Certificate of Analysis) is a formal document that attests to Combretastatin A1 Diphosphate's compliance with Combretastatin A1 Diphosphate specifications and serves as a tool for batch-level quality control.
Combretastatin A1 Diphosphate CoA mostly includes findings from lab analyses of a specific batch. For each Combretastatin A1 Diphosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Combretastatin A1 Diphosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Combretastatin A1 Diphosphate EP), Combretastatin A1 Diphosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Combretastatin A1 Diphosphate USP).
LOOKING FOR A SUPPLIER?
